1. Home
  2. ANVS vs CHCI Comparison

ANVS vs CHCI Comparison

Compare ANVS & CHCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$1.31

Market Cap

76.6M

Sector

Health Care

ML Signal

HOLD

CHCI

Comstock Holding Companies Inc.

N/A

Current Price

$20.87

Market Cap

206.2M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
ANVS
CHCI
Founded
2008
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
76.6M
206.2M
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
ANVS
CHCI
Price
$1.31
$20.87
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$13.50
N/A
AVG Volume (30 Days)
848.9K
31.7K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
39.39
N/A
EPS
N/A
0.09
Revenue
N/A
$62,861,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$235.00
Revenue Growth
N/A
22.55
52 Week Low
$1.32
$10.14
52 Week High
$5.50
$21.69

Technical Indicators

Market Signals
Indicator
ANVS
CHCI
Relative Strength Index (RSI) 25.62 74.04
Support Level N/A $17.64
Resistance Level $2.02 N/A
Average True Range (ATR) 0.10 1.06
MACD -0.05 0.15
Stochastic Oscillator 0.83 84.74

Price Performance

Historical Comparison
ANVS
CHCI

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

About CHCI Comstock Holding Companies Inc.

Comstock Holding Co Inc is a developer and manager of mixed-use and transit-oriented properties with operations that are majorly focused on the Washington, D.C. metropolitan area. It provides a range of services such as asset management, property management, development and construction management, and other real estate-related services to its asset-owning clients, composed predominantly of institutional real estate investors, high net worth family offices, financial institutions, and governmental bodies seeking to enhance their surrounding communities by developing real estate through public-private partnerships.

Share on Social Networks: